Insider trade

CEO sold ~$1.34M of CLOV shares in the open market

Traded Oct 1, 2026 · Filed Oct 3, 2026

~$1.34M
Approx. value · 319K sh @ $4.19: 9.14M
Holds after · shares reported: +8.8%
Since filing · from the first close after the filing, $4.23 → $4.60 on Oct 6, S&P 500 +2.0%

Why it stands out

The CEO of Clover Health Investments, Corp. /De sold $1.34M of Clover Health Investments, Corp. /De shares. The filing references tax withholding.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEO$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,335,797

Shares × reported transaction price

Timing vs results

57 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 1, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on January 1, 2023. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Automatic saleFiled yesterday

Planned, from payFiled 2d ago

Filed 4d ago

Traded Sep 30 · filed 3 days later

Compensation award — excluded from discretionary-purchase analysis.